Ask AI
ProCE Banner Activity

Interactive Decision Support Tool: Global MCL Expert Treatment Guidance

Tool

Get recommendations from 4 global experts on MCL for your specific patient case using this interactive decision support tool.

Released: February 21, 2024

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Disclosure

Primary Author

Marco Ladetto, MD

Associate Professor in Hematology
University of Eastern Piedmont
Director of Hematology Division
Hospital Company Saints Anthony and Biagio and Cesare Arrigo
Alessandria, Italy

Marco Ladetto, MD: consultant/advisor/speaker: AbbVie, ADC Therapeutics, Amgen, BeiGene, Celgene/Bristol-Myers Squibb, Gentili, Gilead/Kite, GSKI, Incyte, Jazz, Johnson & Johnson, Lilly, Novartis, Regeneron, Roche.

Ana Marin-Niebla, MD, PhD

Lymphoma Unit, Hematology Department
Vall d’Hebron Institute of Oncology (VHIO)
Hospital Universitario Vall d’Hebron
Barcelona, Spain

Ana Marin-Niebla, MD, PhD: consultant/advisor/speaker: AbbVie, AstraZeneca, Gilead Kite, Janssen, Lilly, Takeda,

Guilherme Perini, MD

Head
Center of Excellence in Lymphoma
Hospital Israelita Albert Einstein
Sao Paulo, Brazil

Guilherme Fleury Perini, MD: consultant/advisor/speaker: AstraZeneca, Janssen, Lilly, Merck Sharp & Dohme.

Max S. Topp, MD

Head of Hematology
Associate Professor of Medicine
Medical Clinic and Polyclinic
University Hospital Wurzburg
Wurzburg, Germany

Max Topp, MD, has no relevant financial relationships to disclose.